Exploring the Potential for Moral Hazard When Clinical Trial Research is Conducted in Rural Communities: Do
Ann Freeman Cook1, Helena Hoas
1Department of Psychology - Corbin 341, The University of Montana, Missoula, MT, 59812-7397, USA, ann.cook@umontana.edu.
Summary
Clinical trials in rural areas present ethical challenges, potentially compromising patient protection. Researchers found that clinicians struggle to balance patient needs with research demands, often overlooking risks in dual relationships.
Area of Science:
- Clinical research ethics
- Rural health disparities
- Human subject protection
Background:
- Clinical research has shifted from academic centers to community settings, including rural areas.
- This migration introduces potential moral hazards and challenges to human subject protection standards.
- Understanding the motivations behind rural clinical trial conduct is crucial.
Purpose of the Study:
- To explore the motivations influencing decisions to conduct clinical trial research in rural community settings.
- To examine the impact of budgetary factors on study decisions and participant information dissemination.
- To assess the willingness of clinicians and coordinators to enroll patients in such studies.
Main Methods:
- Conducted semi-structured interviews with 80 participants involved in clinical trials with rural subjects.
- Examined the influence of budget, information sharing, and enrollment willingness.
- Focused on understanding the ethical considerations in rural research environments.
Main Results:
- Clinical trial research in rural settings challenges clinicians' ability to balance patient needs with research enterprise demands.
- Few respondents recognized the moral risks associated with dual relationships (patient vs. industry interests).
- Budgetary factors and information conveyance methods were key considerations in study decisions.
Conclusions:
- Re-examination of human subject protection is necessary as clinical research integrates into medical care delivery, even in rural areas.
- The unique context of rural research necessitates a critical review of ethical safeguards and dual relationship management.
- Ensuring robust patient protection requires addressing the complexities of industry-sponsored research in community settings.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
3.1K
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.5K
Related Concept Videos
01:56Ethics in Research
26.3K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.3K
01:16Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
01:11Blinding
4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
01:12Hazard Ratio
737
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
737